Asking for support shows self-awareness and commitment to growth. Sandra Lee, Asia CEO at London-based insurer BMS Group Ltd.

Proposed transaction is a reverse takeover transaction with 1317220 B.C. Ltd.Concurrent $10 million equity financing brokered by Clarus ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Psoriatic arthritis (PsA) is a chronic inflammatory condition that affects approximately 112 per 100,000 adults worldwide. It ...

Orally-active mavacamten – which was acquired by BMS when it bought MyoKardia for ... study's main goal compared to 17% of the placebo group. Patients were deemed to have met the treatment ...

BREYANZI has significant market potential due to its innovative approach as a CD19-directed chimeric antigen receptor (CAR) T-cell therapy. The growing prevalence of hematologic malignancies ...

Opdualag – which combines the PD-1 inhibitor nivolumab in BMS' blockbuster cancer drug Opdivo with LAG-3 inhibitor relatlimab – was unable to improve on Opdivo alone in the RELATIVITY-098 ...

The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...

Genius Group (GNS) announced that it has increased its Bitcoin purchases for its Bitcoin Treasury by an additional $2 million to 440 Bitcoin for $42 million, at an average price of $95,519 per ...

Floyd County 4-H will be attending 4-H Residential Camp at the Skelton 4-H Center June 23-27. Please complete a form for each ...

– Full enrollment in cutaneous melanoma dose-expansion arms of Phase 1/1b clinical trial evaluating WTX-124 as monotherapy and in combination with pembrolizumab expected by the end of the first half ...